rhBMP-2在脊柱融合術(shù)中安全性的研究進(jìn)展
[Abstract]:Background: rh BMP-2 has been the focus of bone graft materials since it was discovered, but because it has not been widely used in clinical practice, the discussion about its safety can only stay in the theoretical stage. In recent years, rh BMP-2 has been more and more widely used in spinal fusion, and its adverse events are more and more common in clinic. Common complications include nerve root inflammation, ectopic ossification, osteolysis, and potential carcinogenic effects, as well as urinary system events after ALIF in men. Many scholars have questioned its safety. This article reviews the latest research progress on the safety of rh BMP-2 in spinal surgery. Solutions and suggestions Objective: the purpose of this study is to review the literature, summarize the research progress of rh BMP-2 safety in spinal fusion, in order to improve the understanding of the complications associated with the product, so as to further the clinical safety of the application of CNKI,. Wanfang full-text database, Pubmed,Springerlink database retrieval system to "recombinant human bone morphogenetic protein (rh BMP-2);" Lumbar fusion; complications; osteolysis; retrograde ejaculation "respectively or jointly search for relevant literature, according to their factors are classified and summarized." Results: it was concluded that rh BMP-2 in lumbar fusion could be related to the injury of new nerve root, ectopic ossification, osteolysis, retrograde ejaculation and potential carcinogenic effect. Anterior cervical edema and dysphagia, osteolysis and graft sedimentation, migration and hematoma formation may occur in the cervical spine. Conclusion: the indication of rh BMP-2 should be strictly limited in spinal surgery, and it is not recommended to be used in spinal fusion. It is recommended only for patients who are at greater risk of bone graft non-fusion than use of rh BMP-2, such as pseudoarthropoiesis patients undergoing revision surgery, and elderly patients with osteoporosis. Patients with long-term smoking increased bone healing difficulty and poor quality of autogenous bone. In a word, before applying rh BMP-2, consider carefully and weigh the advantages and disadvantages.
【學(xué)位授予單位】:蚌埠醫(yī)學(xué)院
【學(xué)位級別】:碩士
【學(xué)位授予年份】:2015
【分類號】:R687.3
【相似文獻(xiàn)】
相關(guān)期刊論文 前10條
1 武忠炎;楊曙光;;脊柱融合術(shù)的研究進(jìn)展[J];新疆醫(yī)科大學(xué)學(xué)報;2006年02期
2 王義生;;脊柱融合術(shù)與非融合術(shù)不是相互替代而是互補(bǔ)[J];中國脊柱脊髓雜志;2011年01期
3 葛葉盈;袁力勇;姜曉紅;王秀珍;徐榮明;馬維虎;;保護(hù)性通氣模式對脊柱融合術(shù)老年患者肺功能的影響[J];中南大學(xué)學(xué)報(醫(yī)學(xué)版);2013年01期
4 田禹,陸裕樸,于鳳和;介紹一種后路脊柱融合術(shù)(附162例報告)[J];解放軍醫(yī)學(xué)雜志;1987年01期
5 岳月英;尹勁峰;;脊柱融合術(shù)編碼的探討[J];中國病案;2010年05期
6 王信勝;張備基;張喜善;鄭建森;王俊勤;;肋段切除和哈氏器械矯正脊柱融合術(shù)治療脊柱側(cè)彎畸形8例分析[J];泰山醫(yī)學(xué)院學(xué)報;1993年03期
7 菲琳;;用于脊柱融合術(shù)的腹腔鏡技術(shù)[J];國外醫(yī)學(xué)情報;1994年18期
8 沈永訓(xùn);經(jīng)前路脊柱融合術(shù)后的乳糜漏(附2例報告)[J];中國矯形外科雜志;1995年03期
9 雅德;;非吸煙者的手術(shù)效果較好[J];國外醫(yī)學(xué)情報;2001年05期
10 馬寧 ,李宏;脊柱融合術(shù)后用酮洛酚鎮(zhèn)痛[J];國外醫(yī)學(xué).麻醉學(xué)與復(fù)蘇分冊;2002年02期
相關(guān)會議論文 前4條
1 汪四花;馬姚靜;盛少英;夏一蘭;;運(yùn)動療法在腰椎退行性疾病脊柱融合術(shù)后康復(fù)中的作用[A];全國門急診護(hù)理學(xué)術(shù)交流會議、第14屆全國骨科護(hù)理學(xué)術(shù)交流會議論文匯編[C];2012年
2 徐侃;李方才;陳其昕;陳維善;吳瓊?cè)A;;鄰椎病的治療策略—附9例鄰椎病的治療體會[A];2007年浙江省醫(yī)學(xué)會骨科學(xué)學(xué)術(shù)會議暨浙江省抗癌協(xié)會骨軟腫瘤學(xué)術(shù)會議論文匯編[C];2007年
3 趙應(yīng)川;李明;王志偉;祝曉東;王偉峰;;成人脊柱側(cè)凸后路脊柱融合術(shù)后的肢體平衡(英文)[A];第十九屆中國康協(xié)肢殘康復(fù)學(xué)術(shù)年會論文選集[C];2010年
4 邊鵬;;脊柱融合術(shù)ICD-9-CM-3編碼探討[A];中國醫(yī)院協(xié)會病案管理專業(yè)委員會第二十二屆學(xué)術(shù)會議論文集[C];2013年
相關(guān)碩士學(xué)位論文 前6條
1 馮俊祥;異種凍干骨復(fù)合自體富血小板血漿在兔脊柱融合術(shù)中的實(shí)驗(yàn)研究[D];山西醫(yī)科大學(xué);2015年
2 孟紅亞;rhBMP-2在脊柱融合術(shù)中安全性的研究進(jìn)展[D];蚌埠醫(yī)學(xué)院;2015年
3 朱永潔;脊柱融合術(shù)患者骨形態(tài)發(fā)生蛋白2基因突變檢測[D];青島大學(xué);2007年
4 李樹林;納米晶膠原基質(zhì)骨修復(fù)材料在脊柱融合術(shù)中的遠(yuǎn)期療效觀察[D];廣州中醫(yī)藥大學(xué);2010年
5 何祖勝;脊柱融合術(shù)治療腰椎退行性椎間盤疾病的系統(tǒng)評價[D];新疆醫(yī)科大學(xué);2005年
6 陳永鋒;復(fù)合骨髓基質(zhì)干細(xì)胞的β-磷酸三鈣在兔脊柱后外側(cè)融合中的應(yīng)用研究[D];第四軍醫(yī)大學(xué);2012年
,本文編號:2359643
本文鏈接:http://sikaile.net/yixuelunwen/waikelunwen/2359643.html